← Open Payments lookup

ABIMBOLA OMORUYI: Open Payments

NPI 1679041420 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$560 in 31 payments from 7 companies in 2025. Trend: 2023 $691 · 2024 $584 · 2025 $560

Food & beverage: $560
CompanyPaymentsAmount
ABBVIE INC.8$158
Teva Pharmaceuticals USA, Inc.8$138
Lundbeck LLC6$114
Otsuka America Pharmaceutical, Inc.5$79
Janssen Pharmaceuticals, Inc2$36
E.R. Squibb & Sons, L.L.C.1$18
Alkermes, Inc.1$18

Products named: VRAYLAR, UZEDY, REXULTI, ABILIFY MAINTENA, SPRAVATO, ABILIFY ASIMTUFII, COBENFY, ARISTADA.

Industry payments across NJ — which companies pay providers there.